Washington 2021-22 Biennium Status: Introduced

SSB 5020 — Rx drug price increases

Last action — By resolution, reintroduced and retained in present status.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2021-22 Biennium. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Assessing a penalty on unsupported prescription drug price increases to protect the safety, health, and economic well-being of Washington residents.

Bill Text

We don't have the full text on file for this bill yet.

Read SSB 5020 on the official Washington source →

Action History

  1. By resolution, reintroduced and retained in present status.

Sponsors

  • HLTC(Keiser) · Primary

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 150 not signed on

Sponsors (1)

  • HLTC(Keiser)

Co-sponsors (0)

None.

Not signed on (150)

150 members have not signed on to this bill.

Show all 150 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SSB 5020 do?
Assessing a penalty on unsupported prescription drug price increases to protect the safety, health, and economic well-being of Washington residents.
Who sponsors SSB 5020?
SSB 5020 is sponsored by HLTC(Keiser).
What is the current status of SSB 5020?
This bill died with 2021-22 Biennium. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SSB 5020?
Track SSB 5020 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SSB 5020

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SSB 5020

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →